By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



One MedImmune Way

Gaithersburg  Maryland  20878  U.S.A.
Phone: 301-398-0000 Fax: 301-398-9000


MedImmune is the worldwide biologics business for the AstraZeneca Group. The company has approximately 3,000 employees worldwide and is headquartered in Gaithersburg, Maryland with facilities in Pennsylvania, California, Kentucky, the United Kingdom, and the Netherlands. UK facilities include vaccine manufacturing operations in Speke and antibody discovery and research laboratories in Cambridge.

With two marketed products and an advancing pipeline of promising candidates in the areas of infection, oncology, respiratory disease and inflammation, cardiovascular/gastrointestinal disease and neuroscience, MedImmune strives to provide better medicines to patients, new medical options for physicians and rewarding careers to employees.

Key Statistics

Ownership: Public

Web Site: MedImmune
Employees: 3,000
Symbol: AZN

Company News
FDA Calls AstraZeneca PLC (AZN) and MedImmune (AZN)’s Imfinzi a Breakthrough 7/31/2017 6:41:46 AM
Life Sciences Professionals Name Top 30 Ideal Employers 6/15/2017 10:43:10 AM
Inovio Pharma (INO) Provides Update On Launch Of Combination Trial For HPV-Associated Head & Neck Cancer 5/10/2017 9:13:57 AM
Sanofi Pasteur (SASY.PA) Inks $645 Million RSV Deal With AstraZeneca PLC (AZN)'s MedImmune (AZN) 3/3/2017 5:51:43 AM
WuXi AppTec Release: Novel Anti-IL-6 Antibody For Rheumatoid Arthritis From WuXi-MedImmune (AZN) Joint Venture Receives Clinical Trial Permit (CTP) From CFDA 1/18/2017 7:57:01 AM
MedImmune (AZN) And Abpro Enter Into A Collaborative Agreement For A Novel Bispecific Antibody 11/29/2016 7:48:13 AM
MedImmune (AZN)'s Flumist Vaccine Just Got Another Thumbs Down. This Time It's A Pediatricians Group 9/13/2016 6:17:08 AM
MedImmune (AZN) Release: New CELL Study Presents Groundbreaking Pre-Clinical Work: Developing Immune Therapy To Potentially Treat Serious Influenza A 7/21/2016 2:28:25 PM
AstraZeneca PLC (AZN) Announces MedImmune (AZN) Layoffs, But Does Not Specify Numbers or Location 7/18/2016 7:19:23 AM
Genisphere Signs Collaborative Research, Option To License Agreement With MedImmune (AZN) 6/2/2016 7:08:17 AM